TRACY ADAMS: Open Payments
NPI 1659854958 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,139 in 138 payments from 47 companies in 2025. Trend: 2023 $1,980 · 2024 $2,572 · 2025 $3,139
Food & beverage: $2,969Education: $170
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $231 |
| Merck Sharp & Dohme LLC | 10 | $217 |
| Celgene Corporation | 6 | $176 |
| Janssen Biotech, Inc. | 9 | $173 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| AstraZeneca Pharmaceuticals LP | 6 | $117 |
| Daiichi Sankyo Inc. | 4 | $105 |
| BeOne Medicines USA, Inc. | 5 | $102 |
| SEAGEN INC. | 1 | $99 |
Products named: REBLOZYL, KEYTRUDA, LIBTAYO, OPDIVO, XT CDX, BRUKINSA, KISQALI, Enhertu.
Industry payments across FL — which companies pay providers there.
